Summary
The present study investigates the potential of bone marrow cells from mice tolerant to tumor antigens to repopulate tumor-specific effector T cells. C3H/He mice were inoculated i.v. with 106 10000 R X-irradiated syngeneic X5563 plasmacytoma tumor cells three times at 4-day intervals. This regimen abrogated the ability of spleen cells from these mice to develop anti-X5563 cytotoxic and in vivo protective (tumor-neutralizing) T cell-mediated immunity as induced by i.d. inoculation of viable X5563 cells followed by surgical resection of the tumor. Since such suppression was induced in a tumor-specific way, this represented a state of antitumor tolerance. When bone marrow cells from normal or X5563-tolerant mice were transferred i.v. into 950 R X-irradiated syngeneic C3H/He mice, both groups of recipient mice generated anti-X5563 tumor immunity over a similar time course and to almost the same degree. Anti-X5563 tumor immunity induced in (C3H/He×C57BL/6) F1 mice which had been transferred with bone marrow cells from normal or X5563-tolerant C3H/He mice were mediated by T cells expressing the Ly phenotype of C3H/He, but not of C57BL/6, excluding the possibility that the antitumor effector cells were derived from recipient mice. It was also demonstrated that C3H/He mice which had been reconstituted with normal marrow were rendered tolerant when the tolerance regimen was started 7 weeks, but not 1 week after the bone marrow reconstitution. These results indicate that bone marrow cells from antitumor tolerant mice are not rendered tolerant to the tumor but can provide the potential to repopulate antitumor CTL and in vivo protective effector T cells.
Similar content being viewed by others
References
Bradley SM, Morrissey PJ, Sharrow SO, Singer A (1982) Tolerance of thymocytes to allogeneic I region determinants encountered prethymically. Evidence for expression of anti-Ia receptors by T cell precursors before their entry into the thymus. J Exp Med 155:1638
Chervenak R, Cohen JJ, Miller SD (1983) Clonal abortion of bone marrow T cell precursors. T cells acquire specific antigen reactivity prethymically. J Immunol 131:1688
Cohn ML, Scott DW (1979) Functional differentiation of T cell precursors. I. Parameters of carrier specific tolerance in murine helper T cell precursors. J Immunol 123:2083
Fink PJ, Bevan MJ (1978) H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med 148:766
Fujiwara H, Shearer GM (1981) Suppressive effect of X-irradiated tumor cell presensitization on the induction of syngeneic tumor immunity. II. Oposite effects of intravenous administration of TNP-conjugated tumor cells on the development of anti-tumor and anti-TNP-self cytotoxic effector cells. Cell Immunol 59:181
Fujiwara H, Hamaoka T, Kitagawa M (1978) Suppressive effect of pretreatment with X-irradiated tumor cells on the induction of syngeneic murine tumor system. I. Suppressive versus sensitizing effect on the same pretreatment in 2 tumor systems with different immune responses. Gann 69:793
Fujiwara H, Hamaoka T, Shearer GM, Yamamoto H, Terry WD (1980) The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. J Immunol 124:863
Fujiwara H, Tsuchida T, Mizuochi T, Kohmo T, Hamaoka T (1981) Suppressive effect of X-irradiated tumor cell presensitization on the induction of syngeneic tumor immunity. III. The mechanism of specific suppression in effector T cell clones against tumor-associated transplantation antigens. Gann 72:732
Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T (1984) The role of tumor-specific Lyt-1+2− T cells in eradicating tumor cells in vivo. I. Lyt-1+2− T cells do not require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. J Immunol 133:1671
Gillis S, Union NA, Baker PE, Smith KA (1979) The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes. J Exp Med 149:1460
Hamaoka T, Takai Y, Kosugi A, Mizushima Y, Shima J, Kusama T, Fujiwara H (1985) The augmentation of tumor-specific immunity by utilizing haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity. Cancer Immunol Immunother 20:183
Hashimoto N, Takatsu K, Masuho Y, Kishida K, Hara T, Hamaoka T (1984) Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate. J Immunol 132:129
Hunig T, Bevan MJ (1980) Specificity of cytotoxic T cells from athymic mice. J Exp Med 152:688
Janeway CA, Binz H, Wigzell H (1976) Two different V gene products make up the T-cell receptors. Scand J Immunol 5:993
Jerne NK (1971) The somatic generation of immune recognition. Eur J Immunol 1:1
Kuhara T, Hosono M, Fujiwara M (1981) Studies on the resistance to tolerance induction against human IgG in DDD mice. Cell Immunol 57:377
Maryanski JL, MacDonald HR, Sordat B, Cerottini J-C (1981) Cytolytic T lymphocyte precursor cells in congenitally athymic C57BL/6 nu/nu mice: quantitation, enrichment, and specificity. J Immunol 126:871
Miller RG, Derry HR, Sarjeant BJ (1983) The extent of self-MHC restriction of cytotoxic T cells in nude mice varies from mouse to mouse. J Immunol 130:63
Miller SD, Claman HN (1976) The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. J Immunol 117:1519
Miller SD, Sy MS, Claman HN (1977) The induction of hapten-specific T cell tolerance using hapten-modified lymphoid cells. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol 7:165
Morrissey PJ, Kruisbeek AM, Sharrow SO, Singer A (1982) Tolerance of thymic cytotoxic T lymphocytes to allogeneic H-2 determinants encountered prethymically: evidence for expression of anti-H-2 receptors prior to entry into the thymus. Proc Natl Acad Sci USA 79:2003
Royer HD, Acuto O, Fabbi M, Tizard R, Ramachandran K, JE Smart, Reinherz EL (1985) Genes encoding the Ti subunit of the antigen/MHC receptor undergo rearrangement during intrathymic ontogeny prior to surface T3-Ti Expression. Cell 39:1984
Sanfilippo F, Cohn ML, Scott DW (1976) Effect of carrier-specific tolerance on the generation of helper cell function. Eur J Immunol 6:742
Sato S, Fujiwara H, Kosugi A, Hamaoka T (1987) Studies on the recovery of tumor-specific effector T cells in tolerant mice by applying T-T cell interaction mechanism. Cancer Immunol Immunother 24:121–126
Shearer GM, Rehn TG, Garbarino CA (1975) Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex. J Exp Med 141:1348
Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T (1984) The augmentation of tumor-specific immunity by virus-help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vacciniareactive helper T cells. Eur J Immunol 14:839
Snodgrass HR, Kisielow P, Kiefer M, Steinmetz M, von Boehmer H (1985) Ontogeny of the T cell antigen receptor within the thymus. Nature 313:592
Wagner H, Hardt C, Heeg K, Rollinghoff M, Pfizenmaier K (1980) T-cell derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice. Nature 284:278
Yoshikai Y, Yanagi Y, Suciu-Foca N, Mak TW (1984) Presence of T cell receptor mRNA in functionally distinct T cells and elevation during intrathymic differentiation. Nature 310:506
Zinkernagel RM, Callahan GN, Althage A, Cooper S, Klein PA, Klein J (1978) On the thymus in the differentiation of “H-2 self-recognition” by T cells: evidence for dual recognition? J Exp Med 147:882
Author information
Authors and Affiliations
Additional information
This work was supported by the Special Project Cancer-Bioscience from the Ministry of Education, Science and Culture, Japan
Abbreviations used: MHC, major histocompatibility complex; CTL, cytotoxic T lymphocytes; TNP, trinitrophenyl; C, complement; TNBS; trinitrobenzene sulfonate; MMC, mitomycin C
Rights and permissions
About this article
Cite this article
Fujiwara, H., Sato, S., Kosugi, A. et al. Studies on the recovery from tolerance to tumor antigens. Cancer Immunol Immunother 24, 113–120 (1987). https://doi.org/10.1007/BF00205587
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205587